# EDGAR Filing Document

**Accession Number:** 0001559109
**File Stem:** 0000940400-25-003041
**Filing Date:** 2025-9
**Character Count:** 50220
**Document Hash:** eb76f462e94da51499684b4492632dc5
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0000940400-25-003041.hdr.sgml**: 20250929

**ACCESSION NUMBER**: 0000940400-25-003041

**CONFORMED SUBMISSION TYPE**: NPORT-P

**PUBLIC DOCUMENT COUNT**: 2

**CONFORMED PERIOD OF REPORT**: 20250731

**FILED AS OF DATE**: 20250929

**DATE AS OF CHANGE**: 20250929

**PERIOD START**: 20251031

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** ETFis Series Trust I
- **CENTRAL INDEX KEY:** 0001559109

**ORGANIZATION NAME:**
- **EIN:** 000000000
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1031

**FILING VALUES:**
- **FORM TYPE:** NPORT-P
- **SEC ACT:** 1940 Act
- **SEC FILE NUMBER:** 811-22819
- **FILM NUMBER:** 251354591

**BUSINESS ADDRESS:**
- **STREET 1:** 1301 AVENUE OF THE AMERICAS
- **STREET 2:** 16TH FLOOR
- **CITY:** NEW YORK
- **STATE:** NY
- **ZIP:** 10019
- **BUSINESS PHONE:** 2125934383

**MAIL ADDRESS:**
- **STREET 1:** 1301 AVENUE OF THE AMERICAS
- **STREET 2:** 16TH FLOOR
- **CITY:** NEW YORK
- **STATE:** NY
- **ZIP:** 10019

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** ETF Actively Managed Trust
- **DATE OF NAME CHANGE:** 20120926

## Series and Classes Contracts Data

### Virtus LifeSci Biotech Clinical Trials ETF (Series ID: S000047353)

| Class ID   | Class Name                                 | Ticker Symbol   |
|:---|:---|:---|
| C000148681 | Virtus LifeSci Biotech Clinical Trials ETF | BBC             |

## Nport-Ex

Schedule of Investments - Virtus LifeSci Biotech Clinical Trials ETF

July 31, 2025 (unaudited)

---

| | | |
|:---|:---|:---|
| **Security Description** | **Shares** | **Value** |
| **COMMON STOCKS - 98.9%** |  |  |
| **Health Care - 98.9%** |  |  |
| 89bio, Inc.\* | 12649 | $120165 |
| AbCellera Biologics, Inc. (Canada)\*<sup>(1)</sup> | 38628 | 172667 |
| Akero Therapeutics, Inc.\* | 2272 | 110987 |
| Allogene Therapeutics, Inc.\*<sup>(1)</sup> | 86914 | 106905 |
| Altimmune, Inc.\*<sup>(1)</sup> | 17018 | 62796 |
| AnaptysBio, Inc.\* | 5198 | 127611 |
| Annexon, Inc.\* | 44900 | 107760 |
| Apogee Therapeutics, Inc.\* | 2907 | 111222 |
| Arbutus Biopharma Corp.\*<sup>(1)</sup> | 33989 | 111484 |
| Arcellx, Inc.\* | 1829 | 130572 |
| Arcturus Therapeutics Holdings, Inc.\* | 9627 | 117546 |
| Arcus Biosciences, Inc.\* | 13014 | 118818 |
| Arcutis Biotherapeutics, Inc.\* | 9013 | 131410 |
| ArriVent Biopharma, Inc.\*<sup>(1)</sup> | 5149 | 100457 |
| Arrowhead Pharmaceuticals, Inc.\* | 7502 | 118532 |
| Arvinas, Inc.\* | 16074 | 119591 |
| Astria Therapeutics, Inc.\* | 21728 | 150358 |
| Autolus Therapeutics PLC (United Kingdom)\*<sup>(2)</sup> | 56595 | 135828 |
| Avidity Biosciences, Inc.\* | 3786 | 138984 |
| Beam Therapeutics, Inc.\* | 6977 | 137517 |
| Belite Bio, Inc.\*<sup>(1)(2)</sup> | 1958 | 127290 |
| Bicara Therapeutics, Inc.\*<sup>(1)</sup> | 10517 | 116844 |
| Bicycle Therapeutics PLC (United Kingdom)\*<sup>(2)</sup> | 14002 | 119297 |
| Biohaven Ltd.\* | 7805 | 117856 |
| Capricor Therapeutics, Inc.\*<sup>(1)</sup> | 8729 | 71403 |
| Cartesian Therapeutics, Inc.\*<sup>(1)</sup> | 11883 | 152221 |
| Celcuity, Inc.\*<sup>(1)</sup> | 9688 | 379431 |
| Celldex Therapeutics, Inc.\* | 5979 | 131418 |
| Centessa Pharmaceuticals PLC\*<sup>(2)</sup> | 10106 | 173520 |
| CG oncology, Inc.\* | 4592 | 122560 |
| Cogent Biosciences, Inc.\* | 16853 | 192461 |
| Compass Pathways PLC (United Kingdom)\*<sup>(2)</sup> | 26920 | 117102 |
| Corvus Pharmaceuticals, Inc.\*<sup>(1)</sup> | 28698 | 119671 |
| Crinetics Pharmaceuticals, Inc.\* | 3782 | 108127 |
| Cullinan Therapeutics, Inc.\* | 13595 | 105633 |
| CureVac NV (Germany)\* | 21728 | 117114 |
| Cytokinetics, Inc.\* | 3665 | 137951 |
| Denali Therapeutics, Inc.\* | 8153 | 112756 |
| Dianthus Therapeutics, Inc.\* | 6308 | 130386 |
| Disc Medicine, Inc.\* | 2308 | 137926 |
| Dyne Therapeutics, Inc.\* | 8415 | 82888 |
| Edgewise Therapeutics, Inc.\* | 7891 | 112526 |
| Enliven Therapeutics, Inc.\*<sup>(1)</sup> | 6189 | 116415 |
| Entrada Therapeutics, Inc.\* | 15501 | 91146 |
| Erasca, Inc.\* | 79529 | 112534 |
| EyePoint Pharmaceuticals, Inc.\* | 13734 | 134868 |
| GH Research PLC (Ireland)\* | 9484 | 136190 |
| Ideaya Biosciences, Inc.\* | 5461 | 132975 |
| Immatics NV (Germany)\* | 19817 | 127820 |
| Immunome, Inc.\* | 12429 | 130753 |
| Immunovant, Inc.\*<sup>(1)</sup> | 7634 | 122755 |
| Intellia Therapeutics, Inc.\* | 14572 | 169618 |
| iTeos Therapeutics, Inc.\* | 12192 | 123627 |
| Janux Therapeutics, Inc.\* | 4761 | 114335 |
| KalVista Pharmaceuticals, Inc.\* | 9296 | 126704 |
| Keros Therapeutics, Inc.\* | 8921 | 127749 |
| Kura Oncology, Inc.\* | 18270 | 110533 |
| Kymera Therapeutics, Inc.\*<sup>(1)</sup> | 2573 | 112569 |

---

---

| | | |
|:---|:---|:---|
| **Security Description** | **Shares** | **Value** |
| **COMMON STOCKS (continued)** |  |  |
| **Health Care (continued)** |  |  |
| LENZ Therapeutics, Inc.\*<sup>(1)</sup> | 4114 | $122474 |
| Liquidia Corp.\* | 8421 | 157388 |
| Maze Therapeutics, Inc.\*<sup>(1)</sup> | 8980 | 132455 |
| MBX Biosciences, Inc.\*<sup>(1)</sup> | 11351 | 150401 |
| Mereo Biopharma Group PLC (United Kingdom)\*<sup>(2)</sup> | 43769 | 73970 |
| Merus NV (Netherlands)\* | 2197 | 145529 |
| Metsera, Inc.\*<sup>(1)</sup> | 3519 | 116092 |
| Mind Medicine MindMed, Inc.\* | 16668 | 151512 |
| Mineralys Therapeutics, Inc.\* | 8155 | 115393 |
| Monte Rosa Therapeutics, Inc.\* | 24732 | 122423 |
| MoonLake Immunotherapeutics\* | 2764 | 139416 |
| Neurogene, Inc.\*<sup>(1)</sup> | 5965 | 129858 |
| Newamsterdam Pharma Co. NV (Netherlands)\* | 5786 | 126193 |
| Nurix Therapeutics, Inc.\* | 10174 | 114559 |
| Nuvalent, Inc. Class A\*<sup>(1)</sup> | 1562 | 122383 |
| Nuvation Bio, Inc.\*<sup>(1)</sup> | 67226 | 158653 |
| Olema Pharmaceuticals, Inc.\*<sup>(1)</sup> | 29970 | 154046 |
| ORIC Pharmaceuticals, Inc.\* | 12583 | 125453 |
| Pharvaris NV (Netherlands)\* | 7062 | 140393 |
| Praxis Precision Medicines, Inc.\* | 2702 | 146502 |
| Protagonist Therapeutics, Inc.\* | 2160 | 116338 |
| Prothena Corp. PLC (Ireland)\* | 24000 | 164880 |
| Rapport Therapeutics, Inc.\* | 10923 | 156854 |
| Recursion Pharmaceuticals, Inc.<br> Class A\*<sup>(1)</sup> | 23536 | 140039 |
| REGENXBIO, Inc.\* | 11929 | 101516 |
| Relay Therapeutics, Inc.\* | 35269 | 124147 |
| Replimune Group, Inc.\*<sup>(1)</sup> | 12309 | 86532 |
| Revolution Medicines, Inc.\* | 2960 | 110319 |
| Rocket Pharmaceuticals, Inc.\* | 39635 | 120887 |
| Sana Biotechnology, Inc.\*<sup>(1)</sup> | 47905 | 194494 |
| Savara, Inc.\* | 53840 | 139446 |
| Scholar Rock Holding Corp.\* | 3652 | 135307 |
| Silence Therapeutics PLC (United Kingdom)\*<sup>(1)(2)</sup> | 21787 | 134208 |
| Sionna Therapeutics, Inc.\*<sup>(1)</sup> | 7162 | 120035 |
| Soleno Therapeutics, Inc.\* | 1517 | 131175 |
| Spyre Therapeutics, Inc.\* | 6871 | 116601 |
| Stoke Therapeutics, Inc.\* | 10294 | 132278 |
| Structure Therapeutics, Inc.\*<sup>(2)</sup> | 5476 | 97473 |
| Summit Therapeutics, Inc.\*<sup>(1)</sup> | 6036 | 159169 |
| Syndax Pharmaceuticals, Inc.\* | 11404 | 113128 |
| Tango Therapeutics, Inc.\*<sup>(1)</sup> | 24095 | 145534 |
| Taysha Gene Therapies, Inc.\*<sup>(1)</sup> | 45917 | 125353 |
| Tectonic Therapeutic, Inc.\* | 5422 | 120314 |
| Terns Pharmaceuticals, Inc.\* | 30962 | 180508 |
| Tourmaline Bio, Inc.\* | 6115 | 135325 |
| Tyra Biosciences, Inc.\*<sup>(1)</sup> | 11779 | 128744 |
| uniQure NV (Netherlands)\* | 7610 | 105931 |
| Upstream Bio, Inc.\*<sup>(1)</sup> | 10526 | 161153 |
| Vaxcyte, Inc.\* | 3531 | 119877 |
| Vera Therapeutics, Inc.\* | 5403 | 112328 |
| Viking Therapeutics, Inc.\*<sup>(1)</sup> | 4257 | 138650 |
| Vir Biotechnology, Inc.\* | 23310 | 118182 |
| Viridian Therapeutics, Inc.\* | 7765 | 136043 |
| WaVe Life Sciences Ltd.\* | 16900 | 136890 |
| Xencor, Inc.\* | 12903 | 107353 |
| Xenon Pharmaceuticals, Inc. (Canada)\* | 3710 | 113303 |
| Xeris Biopharma Holdings, Inc.\* | 27529 | 140123 |
| Zymeworks, Inc.\* | 9288 | 116657 |

---

Schedule of Investments - Virtus LifeSci Biotech Clinical Trials ETF (continued)

July 31, 2025 (unaudited)

---

| | | |
|:---|:---|:---|
| **Security Description** | **Shares** | **Value** |
| **COMMON STOCKS (continued)** | | |
| **Health Care (continued)** | | |
| Total Health Care |  | $14990369 |
| **Total Common Stocks** |  |  |
| (Cost $17,113,973) |  | **14990369** |
| **SECURITIES LENDING COLLATERAL - 15.4%** |  |  |
| **Money Market Fund - 15.4%** |  |  |
| Dreyfus Government Cash Management Fund, Institutional Shares, 4.20%<sup>(3)(4)</sup> |  |  |
| (Cost $2,328,672) | 2328672 | **2328672** |
| **TOTAL INVESTMENTS - 114.3%** |  |  |
| (Cost $19,442,645) |  | **17319041** |
| Liabilities in Excess of Other Assets - (14.3)% |  | (2173226) |
| **Net Assets - 100.0%** |  | $**15145815** |

---

\* Non-income producing security.

(1) All or a portion of the security was on loan. The aggregate market value of securities on loan was $3,169,235; total market value of collateral held by the Fund was $3,350,620. Market value of the collateral held includes non-cash U.S. Treasury securities having a value of $1,021,948.

(2) American Depositary Receipts.

(3) Represents securities purchased with cash collateral received for securities on loan.

(4) The rate shown reflects the seven-day yield as of July 31, 2025.

Schedule of Investments - Virtus LifeSci Biotech Clinical Trials ETF (continued)

July 31, 2025 (unaudited)

**Fair Value Measurements**

The Fund utilizes a fair value hierarchy which prioritizes the inputs to valuation techniques used to measure fair value into three broad levels. Level 1 includes unadjusted quoted prices in active markets for identical assets or liabilities that the Fund has the ability to access. Level 2 includes observable inputs other than quoted prices included in Level 1 that are observable for the asset or liability, either directly or indirectly. These inputs may include quoted prices for the identical instrument on an inactive market, prices for similar securities, interest rates, prepayment speeds, credit risk, yield curves, default rates and similar data. Level 3 includes unobservable inputs for the asset or liability, to the extent relevant observable inputs are not available; representing the Fund's own assumptions about the assumptions a market participant would use in valuing the asset or liability, and would be based on the best information available. The inputs or methodology used for valuing securities are not necessarily an indication of the risk associated with investing in those securities.

The following table summarizes valuation of the Fund's investments under the fair value hierarchy levels as of July 31, 2025.

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **Level 1** | **Level 2** | **Level 3** | **Total** |
| **Asset Valuation Inputs** |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Common Stocks | $14990369 | $— | $— | $14990369 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Money Market Fund | 2328672 |  |  | 2328672 |
| **Total** | $**17319041** | $**—** | $**—** | $**17319041** |

---

## Form NPORT-P: Monthly Portfolio Investments Report

### NPORT-P: Part A: General Information

**Item A.1. Information about the Registrant.**

- **a. Name of Registrant:** ETFis Series Trust I

- **b. Investment Company Act file number:** 811-22819

- **c. CIK number of Registrant:** 0001559109

- **d. LEI of Registrant:** 5493002CWTVLBPSYFT98

- **e. Address and telephone number of Registrant.**

  - **Street Address 1:** 31 West 52nd Street

  - **City:** New York

  - **State:** NY

  - **Foreign country:** US

  - **Zip / Postal Code:** 10019

  - **Telephone number:** 347-903-7347

**Item A.2. Information about the Series.**

- **a. Name of Series:** Virtus LifeSci Biotech Clinical Trials ETF

- **b. EDGAR series identifier (if any):** S000047353

- **c. LEI of Series:** 549300YTBZ16PIXEKJ82

**Item A.3. Reporting period.**

- **a. Date of fiscal year-end:** 2025-10-31

- **b. Date as of which information is reported:** 2025-07-31

**Item A.4. Final filing**

Does the Fund anticipate that this will be its final filing on Form N-PORT? **No**

### Fund Information

**Total Assets:** $17483187.07

**Total Liabilities:** $2337377.83

**Net Assets:** $15145809.24

**Cash Not Reported:** $154329.59

**Monthly Return Information**

| Class               | Month 1 Return (%)   | Month 2 Return (%)   | Month 3 Return (%)   |
|:---|:---|:---|:---|
| Class ID C000148681 | -5.13%               | 5.96%                | 12.24%               |

**Monthly Gains & Losses**

| Period   | Net Realized Gain/Loss   | Net Unrealized Appreciation/Depreciation   |
|:---|:---|:---|
| Month 1  | $198245.61               | $-1114398.47                               |
| Month 2  | $-1590639.10             | $2065598.38                                |
| Month 3  | $-9339.44                | $1368971.02                                |

### Schedule of Portfolio Investments

| Name                           | Title                              | Identifiers                                   | Payoff Profile   | Asset Category   | Issuer Category   | Country   |   Balance | Units   | Value (USD)   | % of Net Assets   | Maturity Date   | Coupon Type   | Annualized Rate (%)   | Restricted?   |   Fair Value Level | Lending Status   |
|:---|:---|:---|:---|:---|:---|:---|---:|:---|:---|:---|:---|:---|:---|:---|---:|:---|
| Pharvaris NV                   | Pharvaris NV                       | CUSIP: 000000000<br>LEI: 9845003BE146D3B75D32 | Long             | EC               | CORP              | NL        |      7062 | NS      | $140392.56    | 0.93%             |  |  |  | No            |                  1 | On Loan: No      |
| Avidity Biosciences Inc        | Avidity Biosciences Inc            | CUSIP: 05370A108<br>LEI: N/A                  | Long             | EC               | CORP              | US        |      3786 | NS      | $138984.06    | 0.92%             |  |  |  | No            |                  1 | On Loan: No      |
| Keros Therapeutics Inc         | Keros Therapeutics Inc             | CUSIP: 492327101<br>LEI: N/A                  | Long             | EC               | CORP              | US        |      8921 | NS      | $127748.72    | 0.84%             |  |  |  | No            |                  1 | On Loan: No      |
| Centessa Pharmaceuticals PLC   | Centessa Pharmaceuticals PLC       | CUSIP: 152309100<br>LEI: 213800GIDAARDSKOI827 | Long             | EC               | CORP              | US        |     10106 | NS      | $173520.02    | 1.15%             |  |  |  | No            |                  1 | On Loan: No      |
| Savara Inc                     | Savara Inc                         | CUSIP: 805111101<br>LEI: 5493002JO0WM3YMJXG33 | Long             | EC               | CORP              | US        |     53840 | NS      | $139445.60    | 0.92%             |  |  |  | No            |                  1 | On Loan: No      |
| ArriVent Biopharma Inc         | ArriVent Biopharma Inc             | CUSIP: 04272N102<br>LEI: N/A                  | Long             | EC               | CORP              | US        |      5149 | NS      | $100456.99    | 0.66%             |  |  |  | No            |                  1 | On Loan: —       |
| Kura Oncology Inc              | Kura Oncology Inc                  | CUSIP: 50127T109<br>LEI: 5493005QORQTZCZYOP39 | Long             | EC               | CORP              | US        |     18270 | NS      | $110533.50    | 0.73%             |  |  |  | No            |                  1 | On Loan: No      |
| Cogent Biosciences Inc         | Cogent Biosciences Inc             | CUSIP: 19240Q201<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     16853 | NS      | $192461.26    | 1.27%             |  |  |  | No            |                  1 | On Loan: No      |
| Arcturus Therapeutics Holdings | Arcturus Therapeutics Holdings Inc | CUSIP: 03969T109<br>LEI: N/A                  | Long             | EC               | CORP              | US        |      9627 | NS      | $117545.67    | 0.78%             |  |  |  | No            |                  1 | On Loan: No      |
| Allogene Therapeutics Inc      | Allogene Therapeutics Inc          | CUSIP: 019770106<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     86914 | NS      | $106904.22    | 0.71%             |  |  |  | No            |                  1 | On Loan: —       |
| Taysha Gene Therapies Inc      | Taysha Gene Therapies Inc          | CUSIP: 877619106<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     45917 | NS      | $125353.41    | 0.83%             |  |  |  | No            |                  1 | On Loan: —       |
| EyePoint Pharmaceuticals Inc   | EyePoint Pharmaceuticals Inc       | CUSIP: 30233G209<br>LEI: 549300QE1RU34T50MR69 | Long             | EC               | CORP              | US        |     13734 | NS      | $134867.88    | 0.89%             |  |  |  | No            |                  1 | On Loan: No      |
| Scholar Rock Holding Corp      | Scholar Rock Holding Corp          | CUSIP: 80706P103<br>LEI: 549300Z1FLPGL4OWJ459 | Long             | EC               | CORP              | US        |      3652 | NS      | $135306.60    | 0.89%             |  |  |  | No            |                  1 | On Loan: No      |
| Compass Pathways Plc           | Compass Pathways Plc               | CUSIP: 20451W101<br>LEI: 213800N7CUZIC6QSTZ31 | Long             | EC               | CORP              | GB        |     26920 | NS      | $117102.00    | 0.77%             |  |  |  | No            |                  1 | On Loan: No      |
| Immatics NV                    | Immatics NV                        | CUSIP: 000000000<br>LEI: 984500DC691EZ96AF394 | Long             | EC               | CORP              | DE        |     19817 | NS      | $127819.65    | 0.84%             |  |  |  | No            |                  1 | On Loan: No      |
| Terns Pharmaceuticals Inc      | Terns Pharmaceuticals Inc          | CUSIP: 880881107<br>LEI: 254900S1ZDQMF4MYP709 | Long             | EC               | CORP              | US        |     30962 | NS      | $180508.46    | 1.19%             |  |  |  | No            |                  1 | On Loan: No      |
| Viridian Therapeutics Inc      | Viridian Therapeutics Inc          | CUSIP: 92790C104<br>LEI: 549300C775BNYF550E70 | Long             | EC               | CORP              | US        |      7765 | NS      | $136042.80    | 0.90%             |  |  |  | No            |                  1 | On Loan: No      |
| MoonLake Immunotherapeutics    | MoonLake Immunotherapeutics        | CUSIP: 61559X104<br>LEI: N/A                  | Long             | EC               | CORP              | CH        |      2764 | NS      | $139416.16    | 0.92%             |  |  |  | No            |                  1 | On Loan: No      |
| Celcuity Inc                   | Celcuity Inc                       | CUSIP: 15102K100<br>LEI: 25490070W7UU7W2SEY87 | Long             | EC               | CORP              | US        |      9688 | NS      | $379430.52    | 2.51%             |  |  |  | No            |                  1 | On Loan: —       |
| Capricor Therapeutics Inc      | Capricor Therapeutics Inc          | CUSIP: 14070B309<br>LEI: 5493002ZI5PDLXV4DX14 | Long             | EC               | CORP              | US        |      8729 | NS      | $71403.22     | 0.47%             |  |  |  | No            |                  1 | On Loan: —       |
| Akero Therapeutics Inc         | Akero Therapeutics Inc             | CUSIP: 00973Y108<br>LEI: 549300SI3KG74LBE2955 | Long             | EC               | CORP              | US        |      2272 | NS      | $110987.20    | 0.73%             |  |  |  | No            |                  1 | On Loan: No      |
| iTeos Therapeutics Inc         | iTeos Therapeutics Inc             | CUSIP: 46565G104<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     12192 | NS      | $123626.88    | 0.82%             |  |  |  | No            |                  1 | On Loan: No      |
| Autolus Therapeutics PLC       | Autolus Therapeutics PLC           | CUSIP: 05280R100<br>LEI: 549300C0KZP8EYROLL02 | Long             | EC               | CORP              | GB        |     56595 | NS      | $135828.00    | 0.90%             |  |  |  | No            |                  1 | On Loan: No      |
| Protagonist Therapeutics Inc   | Protagonist Therapeutics Inc       | CUSIP: 74366E102<br>LEI: N/A                  | Long             | EC               | CORP              | US        |      2160 | NS      | $116337.60    | 0.77%             |  |  |  | No            |                  1 | On Loan: No      |
| Silence Therapeutics PLC       | Silence Therapeutics PLC           | CUSIP: 82686Q101<br>LEI: 213800SSURRJBX85SQ91 | Long             | EC               | CORP              | GB        |     21787 | NS      | $134207.92    | 0.89%             |  |  |  | No            |                  1 | On Loan: —       |
| Astria Therapeutics Inc        | Astria Therapeutics Inc            | CUSIP: 04635X102<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     21728 | NS      | $150357.76    | 0.99%             |  |  |  | No            |                  1 | On Loan: No      |
| Vir Biotechnology Inc          | Vir Biotechnology Inc              | CUSIP: 92764N102<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     23310 | NS      | $118181.70    | 0.78%             |  |  |  | No            |                  1 | On Loan: No      |
| Xencor Inc                     | Xencor Inc                         | CUSIP: 98401F105<br>LEI: 549300V5IF65437JKG30 | Long             | EC               | CORP              | US        |     12903 | NS      | $107352.96    | 0.71%             |  |  |  | No            |                  1 | On Loan: No      |
| Tyra Biosciences Inc           | Tyra Biosciences Inc               | CUSIP: 90240B106<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     11779 | NS      | $128744.47    | 0.85%             |  |  |  | No            |                  1 | On Loan: —       |
| Janux Therapeutics Inc         | Janux Therapeutics Inc             | CUSIP: 47103J105<br>LEI: N/A                  | Long             | EC               | CORP              | US        |      4761 | NS      | $114335.42    | 0.75%             |  |  |  | No            |                  1 | On Loan: No      |
| Crinetics Pharmaceuticals Inc  | Crinetics Pharmaceuticals Inc      | CUSIP: 22663K107<br>LEI: 549300Q1CNFXK5P31D28 | Long             | EC               | CORP              | US        |      3782 | NS      | $108127.38    | 0.71%             |  |  |  | No            |                  1 | On Loan: No      |
| Corvus Pharmaceuticals Inc     | Corvus Pharmaceuticals Inc         | CUSIP: 221015100<br>LEI: 549300I3AVJ8F75NCX65 | Long             | EC               | CORP              | US        |     28698 | NS      | $119670.66    | 0.79%             |  |  |  | No            |                  1 | On Loan: —       |
| Merus NV                       | Merus NV                           | CUSIP: 000000000<br>LEI: 549300W8GPUWU8QNU293 | Long             | EC               | CORP              | NL        |      2197 | NS      | $145529.28    | 0.96%             |  |  |  | No            |                  1 | On Loan: No      |
| Structure Therapeutics Inc     | Structure Therapeutics Inc         | CUSIP: 86366E106<br>LEI: N/A                  | Long             | EC               | CORP              | US        |      5476 | NS      | $97472.80     | 0.64%             |  |  |  | No            |                  1 | On Loan: No      |
| 89bio Inc                      | 89bio Inc                          | CUSIP: 282559103<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     12649 | NS      | $120165.50    | 0.79%             |  |  |  | No            |                  1 | On Loan: No      |
| Maze Therapeutics Inc          | Maze Therapeutics Inc              | CUSIP: 578784100<br>LEI: N/A                  | Long             | EC               | CORP              | US        |      8980 | NS      | $132455.00    | 0.87%             |  |  |  | No            |                  1 | On Loan: —       |
| Biohaven Ltd                   | Biohaven Ltd                       | CUSIP: 000000000<br>LEI: N/A                  | Long             | EC               | CORP              | US        |      7805 | NS      | $117855.50    | 0.78%             |  |  |  | No            |                  1 | On Loan: No      |
| Sana Biotechnology Inc         | Sana Biotechnology Inc             | CUSIP: 799566104<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     47905 | NS      | $194494.30    | 1.28%             |  |  |  | No            |                  1 | On Loan: —       |
| Praxis Precision Medicines Inc | Praxis Precision Medicines Inc     | CUSIP: 74006W207<br>LEI: N/A                  | Long             | EC               | CORP              | US        |      2702 | NS      | $146502.44    | 0.97%             |  |  |  | No            |                  1 | On Loan: No      |
| Upstream Bio Inc               | Upstream Bio Inc                   | CUSIP: 91678A107<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     10526 | NS      | $161153.06    | 1.06%             |  |  |  | No            |                  1 | On Loan: —       |
| Cartesian Therapeutics Inc     | Cartesian Therapeutics Inc         | CUSIP: 816212302<br>LEI: 529900NMN0LACZOL7C43 | Long             | EC               | CORP              | US        |     11883 | NS      | $152221.23    | 1.01%             |  |  |  | No            |                  1 | On Loan: —       |
| Arcus Biosciences Inc          | Arcus Biosciences Inc              | CUSIP: 03969F109<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     13014 | NS      | $118817.82    | 0.78%             |  |  |  | No            |                  1 | On Loan: No      |
| Xenon Pharmaceuticals Inc      | Xenon Pharmaceuticals Inc          | CUSIP: 98420N105<br>LEI: 549300XV44Q9Z1MIPQ03 | Long             | EC               | CORP              | CA        |      3710 | NS      | $113303.40    | 0.75%             |  |  |  | No            |                  1 | On Loan: No      |
| Nurix Therapeutics Inc         | Nurix Therapeutics Inc             | CUSIP: 67080M103<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     10174 | NS      | $114559.24    | 0.76%             |  |  |  | No            |                  1 | On Loan: No      |
| AnaptysBio Inc                 | AnaptysBio Inc                     | CUSIP: 032724106<br>LEI: 529900HH4WQT03IG1A12 | Long             | EC               | CORP              | US        |      5198 | NS      | $127610.90    | 0.84%             |  |  |  | No            |                  1 | On Loan: No      |
| Soleno Therapeutics Inc        | Soleno Therapeutics Inc            | CUSIP: 834203309<br>LEI: 5493003LCY77N7FXK844 | Long             | EC               | CORP              | US        |      1517 | NS      | $131174.99    | 0.87%             |  |  |  | No            |                  1 | On Loan: No      |
| Rocket Pharmaceuticals Inc     | Rocket Pharmaceuticals Inc         | CUSIP: 77313F106<br>LEI: 549300R7VV82YUIN4Y93 | Long             | EC               | CORP              | US        |     39635 | NS      | $120886.75    | 0.80%             |  |  |  | No            |                  1 | On Loan: No      |
| AbCellera Biologics Inc        | AbCellera Biologics Inc            | CUSIP: 00288U106<br>LEI: 9845000861BC95FF9F73 | Long             | EC               | CORP              | CA        |     38628 | NS      | $172667.16    | 1.14%             |  |  |  | No            |                  1 | On Loan: —       |
| Tourmaline Bio Inc             | Tourmaline Bio Inc                 | CUSIP: 89157D105<br>LEI: N/A                  | Long             | EC               | CORP              | US        |      6115 | NS      | $135324.95    | 0.89%             |  |  |  | No            |                  1 | On Loan: No      |
| Spyre Therapeutics Inc         | Spyre Therapeutics Inc             | CUSIP: 00773J202<br>LEI: 52990017AIJPRH3HQH40 | Long             | EC               | CORP              | US        |      6871 | NS      | $116600.87    | 0.77%             |  |  |  | No            |                  1 | On Loan: No      |
| Dyne Therapeutics Inc          | Dyne Therapeutics Inc              | CUSIP: 26818M108<br>LEI: N/A                  | Long             | EC               | CORP              | US        |      8415 | NS      | $82887.75     | 0.55%             |  |  |  | No            |                  1 | On Loan: No      |
| Ideaya Biosciences Inc         | Ideaya Biosciences Inc             | CUSIP: 45166A102<br>LEI: 549300ULW08F62IJML11 | Long             | EC               | CORP              | US        |      5461 | NS      | $132975.35    | 0.88%             |  |  |  | No            |                  1 | On Loan: No      |
| Bicara Therapeutics Inc        | Bicara Therapeutics Inc            | CUSIP: 055477103<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     10517 | NS      | $116843.87    | 0.77%             |  |  |  | No            |                  1 | On Loan: —       |
| Cytokinetics Inc               | Cytokinetics Inc                   | CUSIP: 23282W605<br>LEI: 549300BE5DY1HW7IHA64 | Long             | EC               | CORP              | US        |      3665 | NS      | $137950.60    | 0.91%             |  |  |  | No            |                  1 | On Loan: No      |
| Arcutis Biotherapeutics Inc    | Arcutis Biotherapeutics Inc        | CUSIP: 03969K108<br>LEI: N/A                  | Long             | EC               | CORP              | US        |      9013 | NS      | $131409.54    | 0.87%             |  |  |  | No            |                  1 | On Loan: No      |
| Mereo Biopharma Group PLC      | Mereo Biopharma Group PLC          | CUSIP: 589492107<br>LEI: 213800U8JQHIJOS5AS09 | Long             | EC               | CORP              | GB        |     43769 | NS      | $73969.61     | 0.49%             |  |  |  | No            |                  1 | On Loan: No      |
| Bicycle Therapeutics PLC       | Bicycle Therapeutics PLC           | CUSIP: 088786108<br>LEI: 213800XKUI6R7GKC3E43 | Long             | EC               | CORP              | GB        |     14002 | NS      | $119297.04    | 0.79%             |  |  |  | No            |                  1 | On Loan: No      |
| NEWAMSTERDAM PHARMA CO NV      | NEWAMSTERDAM PHARMA CO NV-27       | CUSIP: 000000000<br>LEI: 984500B6549TF6E14D36 | Long             | EC               | CORP              | NL        |      5786 | NS      | $126192.66    | 0.83%             |  |  |  | No            |                  1 | On Loan: No      |
| Sionna Therapeutics Inc        | Sionna Therapeutics Inc            | CUSIP: 829401108<br>LEI: N/A                  | Long             | EC               | CORP              | US        |      7162 | NS      | $120035.12    | 0.79%             |  |  |  | No            |                  1 | On Loan: —       |
| Neurogene Inc                  | Neurogene Inc                      | CUSIP: 64135M105<br>LEI: 529900A7VIY892SZVW73 | Long             | EC               | CORP              | US        |      5965 | NS      | $129858.05    | 0.86%             |  |  |  | No            |                  1 | On Loan: —       |
| Arcellx Inc                    | Arcellx Inc                        | CUSIP: 03940C100<br>LEI: N/A                  | Long             | EC               | CORP              | US        |      1829 | NS      | $130572.31    | 0.86%             |  |  |  | No            |                  1 | On Loan: No      |
| Zymeworks Inc                  | Zymeworks Inc                      | CUSIP: 98985Y108<br>LEI: 894500AHOYAGYLYZJL67 | Long             | EC               | CORP              | US        |      9288 | NS      | $116657.28    | 0.77%             |  |  |  | No            |                  1 | On Loan: No      |
| DREYFUS GOVERNMENT CASH MANAGE | DREYFUS GOVERNMENT CASH MANAGE     | CUSIP: 000000000<br>LEI: N/A                  | Long             | STIV             | RF                | US        |   2328673 | NS      | $2328673.12   | 15.38%            |  |  |  | No            |                  1 | On Loan: No      |
| Recursion Pharmaceuticals Inc  | Recursion Pharmaceuticals Inc      | CUSIP: 75629V104<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     23536 | NS      | $140039.20    | 0.92%             |  |  |  | No            |                  1 | On Loan: —       |
| Cullinan Therapeutics Inc      | Cullinan Therapeutics Inc          | CUSIP: 230031106<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     13595 | NS      | $105633.15    | 0.70%             |  |  |  | No            |                  1 | On Loan: No      |
| MBX Biosciences Inc            | MBX Biosciences Inc                | CUSIP: 55287L101<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     11351 | NS      | $150400.75    | 0.99%             |  |  |  | No            |                  1 | On Loan: —       |
| Viking Therapeutics Inc        | Viking Therapeutics Inc            | CUSIP: 92686J106<br>LEI: 529900IVC72YPFA25M37 | Long             | EC               | CORP              | US        |      4257 | NS      | $138650.49    | 0.92%             |  |  |  | No            |                  1 | On Loan: —       |
| Vaxcyte Inc                    | Vaxcyte Inc                        | CUSIP: 92243G108<br>LEI: 254900M7NMHTGASX8D95 | Long             | EC               | CORP              | US        |      3531 | NS      | $119877.45    | 0.79%             |  |  |  | No            |                  1 | On Loan: No      |
| Metsera Inc                    | Metsera Inc                        | CUSIP: 59267L107<br>LEI: N/A                  | Long             | EC               | CORP              | US        |      3519 | NS      | $116091.81    | 0.77%             |  |  |  | No            |                  1 | On Loan: —       |
| uniQure NV                     | uniQure NV                         | CUSIP: 000000000<br>LEI: 724500RPCTZLFYJZ3S98 | Long             | EC               | CORP              | NL        |      7610 | NS      | $105931.20    | 0.70%             |  |  |  | No            |                  1 | On Loan: No      |
| Xeris Biopharma Holdings Inc   | Xeris Biopharma Holdings Inc       | CUSIP: 98422E103<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     27529 | NS      | $140122.61    | 0.93%             |  |  |  | No            |                  1 | On Loan: No      |
| Altimmune Inc                  | Altimmune Inc                      | CUSIP: 02155H200<br>LEI: 549300EOYCQ8SW3NVE64 | Long             | EC               | CORP              | US        |     17018 | NS      | $62796.42     | 0.41%             |  |  |  | No            |                  1 | On Loan: —       |
| Nuvation Bio Inc               | Nuvation Bio Inc                   | CUSIP: 67080N101<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     67226 | NS      | $158653.36    | 1.05%             |  |  |  | No            |                  1 | On Loan: —       |
| CureVac NV                     | CureVac NV                         | CUSIP: 000000000<br>LEI: 724500BUT8GAG9LMYN56 | Long             | EC               | CORP              | DE        |     21728 | NS      | $117113.92    | 0.77%             |  |  |  | No            |                  1 | On Loan: No      |
| LENZ Therapeutics Inc          | LENZ Therapeutics Inc              | CUSIP: 52635N103<br>LEI: N/A                  | Long             | EC               | CORP              | US        |      4114 | NS      | $122473.78    | 0.81%             |  |  |  | No            |                  1 | On Loan: —       |
| Erasca Inc                     | Erasca Inc                         | CUSIP: 29479A108<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     79529 | NS      | $112533.54    | 0.74%             |  |  |  | No            |                  1 | On Loan: No      |
| Edgewise Therapeutics Inc      | Edgewise Therapeutics Inc          | CUSIP: 28036F105<br>LEI: N/A                  | Long             | EC               | CORP              | US        |      7891 | NS      | $112525.66    | 0.74%             |  |  |  | No            |                  1 | On Loan: No      |
| Replimune Group Inc            | Replimune Group Inc                | CUSIP: 76029N106<br>LEI: 549300AY704NEIRC4K64 | Long             | EC               | CORP              | US        |     12309 | NS      | $86532.27     | 0.57%             |  |  |  | No            |                  1 | On Loan: —       |
| Summit Therapeutics Inc        | Summit Therapeutics Inc            | CUSIP: 86627T108<br>LEI: N/A                  | Long             | EC               | CORP              | US        |      6036 | NS      | $159169.32    | 1.05%             |  |  |  | No            |                  1 | On Loan: —       |
| KalVista Pharmaceuticals Inc   | KalVista Pharmaceuticals Inc       | CUSIP: 483497103<br>LEI: 529900Q7IDA3WUGRZA51 | Long             | EC               | CORP              | US        |      9296 | NS      | $126704.48    | 0.84%             |  |  |  | No            |                  1 | On Loan: No      |
| Intellia Therapeutics Inc      | Intellia Therapeutics Inc          | CUSIP: 45826J105<br>LEI: 5493002T5BCPE5DZC723 | Long             | EC               | CORP              | US        |     14572 | NS      | $169618.08    | 1.12%             |  |  |  | No            |                  1 | On Loan: No      |
| Kymera Therapeutics Inc        | Kymera Therapeutics Inc            | CUSIP: 501575104<br>LEI: N/A                  | Long             | EC               | CORP              | US        |      2573 | NS      | $112568.75    | 0.74%             |  |  |  | No            |                  1 | On Loan: —       |
| Liquidia Corp                  | Liquidia Corp                      | CUSIP: 53635D202<br>LEI: 549300O826O5VQJTG707 | Long             | EC               | CORP              | US        |      8421 | NS      | $157388.49    | 1.04%             |  |  |  | No            |                  1 | On Loan: No      |
| Tango Therapeutics Inc         | Tango Therapeutics Inc             | CUSIP: 87583X109<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     24095 | NS      | $145533.80    | 0.96%             |  |  |  | No            |                  1 | On Loan: —       |
| Celldex Therapeutics Inc       | Celldex Therapeutics Inc           | CUSIP: 15117B202<br>LEI: 529900F018DMYWH38923 | Long             | EC               | CORP              | US        |      5979 | NS      | $131418.42    | 0.87%             |  |  |  | No            |                  1 | On Loan: No      |
| Belite Bio Inc                 | Belite Bio Inc                     | CUSIP: 07782B104<br>LEI: 984500BD54036BOEAE79 | Long             | EC               | CORP              | US        |      1958 | NS      | $127289.58    | 0.84%             |  |  |  | No            |                  1 | On Loan: —       |
| Mineralys Therapeutics Inc     | Mineralys Therapeutics Inc         | CUSIP: 603170101<br>LEI: N/A                  | Long             | EC               | CORP              | US        |      8155 | NS      | $115393.25    | 0.76%             |  |  |  | No            |                  1 | On Loan: No      |
| Arvinas Inc                    | Arvinas Inc                        | CUSIP: 04335A105<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     16074 | NS      | $119590.56    | 0.79%             |  |  |  | No            |                  1 | On Loan: No      |
| Apogee Therapeutics Inc        | Apogee Therapeutics Inc            | CUSIP: 03770N101<br>LEI: N/A                  | Long             | EC               | CORP              | US        |      2907 | NS      | $111221.82    | 0.73%             |  |  |  | No            |                  1 | On Loan: No      |
| REGENXBIO Inc                  | REGENXBIO Inc                      | CUSIP: 75901B107<br>LEI: 549300EOES47LATSET33 | Long             | EC               | CORP              | US        |     11929 | NS      | $101515.79    | 0.67%             |  |  |  | No            |                  1 | On Loan: No      |
| Rapport Therapeutics Inc       | Rapport Therapeutics Inc           | CUSIP: 75383L102<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     10923 | NS      | $156854.28    | 1.04%             |  |  |  | No            |                  1 | On Loan: No      |
| Immunome Inc                   | Immunome Inc                       | CUSIP: 45257U108<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     12429 | NS      | $130753.08    | 0.86%             |  |  |  | No            |                  1 | On Loan: No      |
| Denali Therapeutics Inc        | Denali Therapeutics Inc            | CUSIP: 24823R105<br>LEI: 549300ZTQ2HO18L3Q830 | Long             | EC               | CORP              | US        |      8153 | NS      | $112755.99    | 0.74%             |  |  |  | No            |                  1 | On Loan: No      |
| Prothena Corp PLC              | Prothena Corp PLC                  | CUSIP: 000000000<br>LEI: 5299009ZXQ8NIIJ8OL30 | Long             | EC               | CORP              | IE        |     24000 | NS      | $164880.00    | 1.09%             |  |  |  | No            |                  1 | On Loan: No      |
| Olema Pharmaceuticals Inc      | Olema Pharmaceuticals Inc          | CUSIP: 68062P106<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     29970 | NS      | $154045.80    | 1.02%             |  |  |  | No            |                  1 | On Loan: —       |
| Dianthus Therapeutics Inc      | Dianthus Therapeutics Inc          | CUSIP: 252828108<br>LEI: 549300Z3N6ODPCOFC890 | Long             | EC               | CORP              | US        |      6308 | NS      | $130386.36    | 0.86%             |  |  |  | No            |                  1 | On Loan: No      |
| Syndax Pharmaceuticals Inc     | Syndax Pharmaceuticals Inc         | CUSIP: 87164F105<br>LEI: 529900OF94TRHKZVBS87 | Long             | EC               | CORP              | US        |     11404 | NS      | $113127.68    | 0.75%             |  |  |  | No            |                  1 | On Loan: No      |
| GH Research PLC                | GH Research PLC                    | CUSIP: 000000000<br>LEI: 875500HKJS7QQG6EWH62 | Long             | EC               | CORP              | IE        |      9484 | NS      | $136190.24    | 0.90%             |  |  |  | No            |                  1 | On Loan: No      |
| Monte Rosa Therapeutics Inc    | Monte Rosa Therapeutics Inc        | CUSIP: 61225M102<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     24732 | NS      | $122423.40    | 0.81%             |  |  |  | No            |                  1 | On Loan: No      |
| Mind Medicine MindMed Inc      | Mind Medicine MindMed Inc          | CUSIP: 60255C885<br>LEI: 549300QY8KN1O6RPFJ13 | Long             | EC               | CORP              | US        |     16668 | NS      | $151512.12    | 1.00%             |  |  |  | No            |                  1 | On Loan: No      |
| Enliven Therapeutics Inc       | Enliven Therapeutics Inc           | CUSIP: 29337E102<br>LEI: N/A                  | Long             | EC               | CORP              | US        |      6189 | NS      | $116415.09    | 0.77%             |  |  |  | No            |                  1 | On Loan: —       |
| Tectonic Therapeutic Inc       | Tectonic Therapeutic Inc           | CUSIP: 878972108<br>LEI: N/A                  | Long             | EC               | CORP              | US        |      5422 | NS      | $120314.18    | 0.79%             |  |  |  | No            |                  1 | On Loan: No      |
| Revolution Medicines Inc       | Revolution Medicines Inc           | CUSIP: 76155X100<br>LEI: 549300JU3X0LBCQ65892 | Long             | EC               | CORP              | US        |      2960 | NS      | $110319.20    | 0.73%             |  |  |  | No            |                  1 | On Loan: No      |
| Entrada Therapeutics Inc       | Entrada Therapeutics Inc           | CUSIP: 29384C108<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     15501 | NS      | $91145.88     | 0.60%             |  |  |  | No            |                  1 | On Loan: No      |
| ORIC Pharmaceuticals Inc       | ORIC Pharmaceuticals Inc           | CUSIP: 68622P109<br>LEI: 54930033FJRNEYBW0L25 | Long             | EC               | CORP              | US        |     12583 | NS      | $125452.51    | 0.83%             |  |  |  | No            |                  1 | On Loan: No      |
| Nuvalent Inc                   | Nuvalent Inc                       | CUSIP: 670703107<br>LEI: N/A                  | Long             | EC               | CORP              | US        |      1562 | NS      | $122382.70    | 0.81%             |  |  |  | No            |                  1 | On Loan: —       |
| Arrowhead Pharmaceuticals Inc  | Arrowhead Pharmaceuticals Inc      | CUSIP: 04280A100<br>LEI: 549300O3CSB8T7OZ3D66 | Long             | EC               | CORP              | US        |      7502 | NS      | $118531.60    | 0.78%             |  |  |  | No            |                  1 | On Loan: No      |
| Disc Medicine Inc              | Disc Medicine Inc                  | CUSIP: 254604101<br>LEI: N/A                  | Long             | EC               | CORP              | US        |      2308 | NS      | $137926.08    | 0.91%             |  |  |  | No            |                  1 | On Loan: No      |
| CG oncology Inc                | CG oncology Inc                    | CUSIP: 156944100<br>LEI: N/A                  | Long             | EC               | CORP              | US        |      4592 | NS      | $122560.48    | 0.81%             |  |  |  | No            |                  1 | On Loan: No      |
| Relay Therapeutics Inc         | Relay Therapeutics Inc             | CUSIP: 75943R102<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     35269 | NS      | $124146.88    | 0.82%             |  |  |  | No            |                  1 | On Loan: No      |
| Immunovant Inc                 | Immunovant Inc                     | CUSIP: 45258J102<br>LEI: N/A                  | Long             | EC               | CORP              | US        |      7634 | NS      | $122754.72    | 0.81%             |  |  |  | No            |                  1 | On Loan: —       |
| Vera Therapeutics Inc          | Vera Therapeutics Inc              | CUSIP: 92337R101<br>LEI: N/A                  | Long             | EC               | CORP              | US        |      5403 | NS      | $112328.37    | 0.74%             |  |  |  | No            |                  1 | On Loan: No      |
| Arbutus Biopharma Corp         | Arbutus Biopharma Corp             | CUSIP: 03879J100<br>LEI: 25490064CESONAUIAS23 | Long             | EC               | CORP              | US        |     33989 | NS      | $111483.92    | 0.74%             |  |  |  | No            |                  1 | On Loan: —       |
| Stoke Therapeutics Inc         | Stoke Therapeutics Inc             | CUSIP: 86150R107<br>LEI: 549300RD25SS2DIJHJ67 | Long             | EC               | CORP              | US        |     10294 | NS      | $132277.90    | 0.87%             |  |  |  | No            |                  1 | On Loan: No      |
| WaVe Life Sciences Ltd         | WaVe Life Sciences Ltd             | CUSIP: 000000000<br>LEI: 54930070006GPKFYZ813 | Long             | EC               | CORP              | US        |     16900 | NS      | $136890.00    | 0.90%             |  |  |  | No            |                  1 | On Loan: No      |
| Beam Therapeutics Inc          | Beam Therapeutics Inc              | CUSIP: 07373V105<br>LEI: N/A                  | Long             | EC               | CORP              | US        |      6977 | NS      | $137516.67    | 0.91%             |  |  |  | No            |                  1 | On Loan: No      |
| Annexon Inc                    | Annexon Inc                        | CUSIP: 03589W102<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     44900 | NS      | $107760.00    | 0.71%             |  |  |  | No            |                  1 | On Loan: No      |

### Signature

**Date Signed:** 2025-09-29

**Name of Applicant:** ETFis Series Trust I

**Signature:** Brinton W. Frith

**Name of Signer:** Brinton W. Frith

**Title:** Treasurer and Principal Financial Officer